Inetetamab (Cipterbin)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Inetetamab (Cipterbin), covering 2023-09-25 to 2023-09-25. Get the full timeline:
Most recent: Clinical Trial Update: Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone. [Phase 2]